Lois Almadrones
Lois Almadrones publishes mostly in Reproductive Medicine, Surgery and Oncology, on topics such as Ovarian cancer diagnosis and treatment, Intraperitoneal and Appendiceal Malignancies and Testicular diseases and treatments.
- World rank
- #671,010 of 7,710,434 ranked researchers
- Rank in United States
- #227,821 of 1,627,098
- Works
- 71
- Citations
- 3.6k
- Citations per work
- 51.1
What does Lois Almadrones research?
Lois Almadrones's work is mostly in Medicine (72%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5172.0%
- Medicine5172.0%
- Everything else1724.4%
- Life Sciences33.6%
- 1Reproductive Medicine24% of their works
- 2Surgery21% of their works
- 3Oncology14% of their works
- 4Pathology and Forensic Medicine8% of their works
- 5Hematology4% of their works
- 6Molecular Biology4% of their works
Research topics
- Ovarian cancer diagnosis and treatment
- Intraperitoneal and Appendiceal Malignancies
- Testicular diseases and treatments
- Chemotherapy-induced organ toxicity mitigation
- Cancer Treatment and Pharmacology
- Endometrial and Cervical Cancer Treatments
- Neuroendocrine Tumor Research Advances
- PARP inhibition in cancer therapy
Which keywords describe Lois Almadrones's research?
The keywords of their largest research topics: Chemotherapy, Cytoreductive Surgery, Genomic Analysis, Ovarian Cancer, Survival Analysis, Colorectal Cancer, Intraperitoneal Chemotherapy and Germ Cell Tumors.
- BRCA Mutation
- Neuroendocrine Tumors
- Cervical Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Cisplatin
- Germ Cell Tumors
- Colorectal Cancer
- Ovarian Cancer
- Cytoreductive Surgery
- Chemotherapy
- Genomic Analysis
- Survival Analysis
- Intraperitoneal Chemotherapy
- Testicular Cancer
- Nephrotoxicity
- Taxanes
- Endometrial Carcinoma
- Pancreatic Neuroendocrine Tumors
- PARP Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Chemotherapy723 topics
- Cytoreductive Surgery682 topics
- Genomic Analysis461 topic
- Ovarian Cancer461 topic
- Survival Analysis333 topics
- Colorectal Cancer221 topic
- Intraperitoneal Chemotherapy221 topic
- Germ Cell Tumors141 topic
- Testicular Cancer141 topic
- Cisplatin121 topic
- Nephrotoxicity121 topic
- Chemotherapy-Induced Peripheral Neuropathy91 topic
- Taxanes91 topic
- Cervical Cancer61 topic
- Endometrial Carcinoma61 topic
- Neuroendocrine Tumors51 topic
- Pancreatic Neuroendocrine Tumors51 topic
- BRCA Mutation41 topic
- PARP Inhibitors41 topic
Where does Lois Almadrones work?
Lois Almadrones's main affiliation in the publication record is Memorial Sloan Kettering Cancer Center, United States.
How many publications and citations does Lois Almadrones have?
OpenAlex counts 71 works and 3,626 citations for Lois Almadrones, an h-index of 32, ranking #671,010 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lois Almadrones. Posts are plain text and can be reported.